Investors

Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.

Stock Quote
NASDAQ: AZTA
Change:
Volume:
Market Cap:
Recent News
Jul 24, 2024

Azenta, Inc. (Nasdaq: AZTA) will announce fiscal third quarter 2024 earnings which ended on June 30, 2024, on Tuesday, August 6, 2024, after the market closes. The Company will host a conference...

Jul 22, 2024

Azenta will provide proteomics technology profiling on up to 20,000 individuals. BURLINGTON, Mass., July 22, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced its participation in...

Jun 04, 2024

Azenta has been Selected by the Crohn's & Colitis Foundation as its Sample Management Services Provider for its Inflammatory Bowel Disease (IBD) CAPTURE and SIRQC Clinical Registries BURLINGTON, Mass.

All Releases

Featured Events
LEARN MORE ABOUT
AZENTA LIFE SCIENCES
Contact Investor Relations

Investor Relations
ir@azenta.com

Sherry Dinsmore
Executive Assistant to CFO
sherry.dinsmore@azenta.com

Transfer Agent:

Computershare
P.O. Box 43006                                   
Providence RI 02940-3006                   
Investor Center web address:
https://www-us.computershare.com/investor

SIGN UP FOR ALERTS AND NEVER MISS INVESTOR UPDATES!

Subscribe

©2024 Azenta, Inc. All rights reserved. | Privacy & Security Policy
Loading data...